chrisvoncsefalvay/vaers-outcomes huggingface dataset:
THE SECOND DOSE WAS INJECTED MORE ON THE INNER SIDE OF MY UPPER LEFT ARM.  SINCE THAT SHOT BEGINNING THE NEXT DAY I HAVE HAD PAIN AND EXTREME WEAKNESS. I CANT PICK NORMAL ITEMS UP OR I DROP THEM DUE TO WEAKNESS AND PAIN. IT IS INTERFERING WITH MY JOB. PICKING UP FILES AND EVEN ANSWERING THE PHONE AS A FRONT DESK RECEPTIONIST I ALMOST DROP THE RECEIVER.  MY GP  HAS REFERRED ME TO AN ORTHOPEDIC DOCTOR FOR ASSESMENT. I HAVE NOT MADE THAT APPOINTMENT YET DUE TO MY WORK SCHEDULE. I PLAN ON MAKING IT VERY SOON.
severe cognitive impairment, at first disorientation followed closely by general cognitive disability with 70% loss of short term memory.  lasted and worsened over 4 days,  Started Prednisone and cleared within 6 hrs by 70% took additional prednisone following day as some regression and cleared in hrs to 98% and holding
pt recv vax NOV96 & devel an inj site rxn w/redness, swelling & itching;the affected area is about the size of a BP cuff (4" x 10");this case was reported by MD;cross reference w/DER0010150960093 to DER0010150960101;
Patient presented to the ED with SOB and weakness for the past 1 month. He reports seeing his PCP twice and given antibiotics and steroids. His son also had similar symptoms to both were advised by PCP to get tested for COVID. The patient initially tested negative however, his son, who he lives with tested positive. In the ED, the patient did test positive for COVID and is assumed to have got this from his son. Patient remains hospitalized receiving remdesivir and steroids. Per the EUA, hospitalizations are to be reported irrespective of attribution to the vaccine
I had an influenza vaccine, but I don't have the exact name. I received it at our local health department at the time. I got ill with a fever, vomiting, dizziness etc... facility told me it was normal. From there, I developed severe anemia. I had tons of work-ups, because I never recovered after the vaccine. It took years of getting worse for doctors to take me seriously.
Started on Valtrex and Prednisone day after patchy eruptions approx 5 days after receiving Zostavax vaccine, pt experienced soreness in torso area, he then broke out in approx 20 mm sore on lf side of torso with 2 more patches following. Still have patches.
woke up with 104 degree fever, severe headache and  weakness and very high blood pressure.. went to the ER . Had CT scan, fluids and x ray of hip. Given pain meds and sent home. Went tprimary doctor one month later for ongoing high blood pressure, stomach pain. Have since been put on 2 blood pressure medications! and had to have gall bladder removed. NEVER had either problem before. Now my vision is getting worse, stays blurry and double.. Have an appointment to see my nurse practitioner for THAT on 8-18th.
"My" HDL that over the years ranged from mid 50's-mid 60's was elevated to 230; "My" HDL that over the years ranged from mid 50's-mid 60's was elevated to 230; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 08:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid and cholesterol. The patient reported that she was healthy except for needing medication for thyroid and cholesterol. The patient's blood pressure had been consistently good. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril 10mg (MANUFACTURER UNKNOWN), levothyroxine 88mcg (MANUFACTURER UNKNOWN) and thiamine (VITAMIN B1); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. It was reported that the patient had no reaction to the vaccine. However, on 13Apr2021 (reported as 7 days later), the patient had routine bloodwork done and noticed her high-density lipoprotein (HDL) that over the years ranged from mid 50's-mid 60's was elevated to 230. This was considered extremely high and she had no explanation to explain what might be different (patient's weight was 103 (unit unspecified)) and she was very active so this made her wonder if it was because of the vaccine she received one week prior. The patient stated, perhaps she should not have had bloodwork done so soon. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "my" HDL that over the years ranged from mid 50's-mid 60's was elevated to 230 was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Metallic taste; loss of taste; loss of smell; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05May2021 at 15:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included paracetamol (TYLENOL) from an unknown date, for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN)  via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 the patient experienced Metallic taste, loss of taste and loss of smell. The patient reported that he felt Metallic taste immediately after and a few hours later loss of taste and smell. No therapeutic measures were taken as a result of the adverse event. The clinical outcome of the event Metallic taste, loss of taste, loss of smell was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
allergy reaction; Itching on my back and my stomach; Hives on my arms, my back, my torso, my stomach and near my collar bone, my chest area; This is a spontaneous report from a contactable consumer. A 55-year-old female patient received first dose of BNT162B2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 15May2021 (Batch/Lot Number: EW0186) as 1ST DOSE,SINGLE for covid-19 immunization. The patient's medical history includes Grave's disease. The patient's concomitant medications were not reported. The patient experienced allergy reaction, itching on my back and my stomach and hives on my arms, my back, my torso, my stomach and near my collar bone, my chest area on unspecified date. Consumer stated, "I had an adverse reaction, allergy reaction from the Pfizer shot. I received first Pfizer BioNTech Covid vaccine on the 15th of May which is Saturday 2 days ago and as Sunday morning, Saturday night I started itching on my back and my stomach and I woke up Sunday morning with hives and they went away Sunday after Sunday evening but when I went back to bed Sunday night I started itching again and this morning I woke up with more hives on my arms, my back, my torso, my stomach and near my collar bone, my chest area. So I called my doctor and they put me on steroids and asked me to call to let you all know." Probed for recent lab work, consumer: "Yes, I did. It was. So, I do not have, it was a physical that I had I know one of the blood work was, it was a physical. I used to have Grave's disease so one of the test was to check my thyroid but I don't know what you call that. Only today I was given a steroid shot. Nothing else, I didn't do any other treatment." The patient underwent lab tests and procedures which included thyroid function test: grave's disease on an unspecified date (I had I know one of the blood work was, it was a physical. I used to have Grave's disease so one of the test was to check my thyroid). Therapeutic measures were taken as a result of allergy reaction, itching on my back and my stomach and hives on my arms, my back, my torso, my stomach and near my collar bone, my chest area. Outcome of the events was unknown.   Information on Lot/Batch number was available. Additional information has been requested
Swelling at injection site immediately vomiting after 30 minutes x 5 for 4 hours total. Fever of 99. Arm still swollen.
Experienced monthly postmenopausal bleeding starting mid-November, 12/12/2021 (12 days), 1/7/2022 (14 days), and 2/2/2022 (17 days).  Other Factors - Started BioIdentical hormone treatment in Jan 2018. Only experience rare stopping is missed a nightly progesterone pill until Jun 2021.  Experienced one-time bleeding event with interaction between Ibuprofen and Fish Oil (bleeding stopped immediately upon stopping Fish Oil).  Took Duexis from end of May 2021 - mid-Oct 2021.  Replaced Duexis with evening dose of Shaklee Recovery PM Complex.  My daughter started menstruation on 11/5/2021 (Dec,/Jan/Feb bleeding started 1-2 days with start of her monthly cycles.)
Numbness on back and front torso, Arms and Hands, Legs and Feet all still ongoing and I am hot most of the time ( I  always was cold and had on sweatshirt etc even in the heat but now I am almost hot and/or sweating)
Within 10 minutes of injection in pt's non-dominant Left upper arm, she developed swelling in Left Gluteus Maximus (possibly lymphatic vessels there). Fever not getter than 100.9 started within 60 minutes and lasted for 2 days. Swelling in Left axilla within 8 hours. Swelling in Left side of body for 4 days Malaise for 4 days. Called Pharmacist and doctor's office within 12 hours of adverse reaction. Tylenol and Advil given to ease pain and swelling as well as Benadryl.
After drawing up the vaccine, I pushed the plunger down when I was administering and when I did the vaccine came out of the top of the syringe below the needle. This was as if the needle was not on the syringe tightly. This actually happened twice with two different needle and syringes. Then when I changed the type of needle and syringe for the 3rd time the patient received the correct dose. I told the patient the dose did not get into her muscle and if it did it was a very very small amount. So I made sure to give the full 0.5 ml dose the third attempt.
Broke out in hives, has tremendous amount of hives; Congested; Entire body is itchy; Hasn't slept much, she's struggling; Some chills; Some fever; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Broke out in hives, has tremendous amount of hives), NASAL CONGESTION (Congested), PRURITUS (Entire body is itchy), INSOMNIA (Hasn't slept much, she's struggling) and CHILLS (Some chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunocompromised and Lyme disease (The patient used to be in a tremendous amount of antibiotics in the past). Concomitant products included VITAMINS NOS for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2021, the patient experienced CHILLS (Some chills) and PYREXIA (Some fever). On 21-Sep-2021, the patient experienced URTICARIA (Broke out in hives, has tremendous amount of hives), NASAL CONGESTION (Congested), PRURITUS (Entire body is itchy) and INSOMNIA (Hasn't slept much, she's struggling). The patient was treated with PREDNISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (Broke out in hives, has tremendous amount of hives), NASAL CONGESTION (Congested), PRURITUS (Entire body is itchy), INSOMNIA (Hasn't slept much, she's struggling), CHILLS (Some chills) and PYREXIA (Some fever) outcome was unknown.            Treatment medicines include Prednisone and Benadryl
Interchange of vaccine products; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient received BNT162b2 (BNT162B2), on 23Feb2021 as dose 1, single (Lot number: EN6203), in left arm, on 16Mar2021 as dose 2, single (Lot number: EP7534), in left arm and on 19Nov2021 as dose 3 (booster), single (Lot number: FJ1620) at the age of 51 years, in left arm for covid-19 immunisation; elasomeran (COVID-19 VACCINE MODERNA), on 21May2022 as dose 4 (booster), single (Lot number: 56MZIA), in left arm and on 05Nov2022 at 12:00 as dose 5 (booster), single (Lot number: O/OH22A), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Amoxicillin, reaction(s): "Known allergies: amoxicillin". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: positive test 4 days after negative; Negative, notes: positive test 4 days after negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Received Hep B, MMR, TD on 06/05/02. Initially noted papules and water blister like lesions initially on face began on 06/20/02. Progressing to neck, arms and legs then abdomen extending to back. Lesions weeped then crusted. Lesions between thighs have progressed until confluent on inner thigh bilaterally. Saw MD on 06/24/02. Prescribed Clarinex. Topical Calidryl. Temp 98.9-feels flushed at time.
So I would say an exacerbation of lime Arthritis, and new diagnosis of Fibromyalgia, the pain never went away. Did local health visit, and was prescribed pregabalin 25mg 4 tablets 2x a day.
Pt has a PMH of CAD s/p CABG, HTN, CKD stage III, and non-insulin dependent DM type 2. Pt developed congestion, rhinorrhea with a sore throat. He was found to have COVID -19 and admitted to the hospital.
Patient's wife described flu-like symptoms such as aches & chills and significant upper arm pain/redness/swelling.
I've had 5 Civid 19 vaccines. I am having brain fog, imbalance and vertigo like symptoms, worsening an constant. Heart palpitations. I've need to 3 ENT's, 2 neurosurgeons, 2 neurologists, 1 cardiologist, 1 pulmonologist, 1 orthopedic dr. I've had Brain and neck MRI/MRA's, CT Angiograms, balance tests, hearing tests, EEG's EKG's. Nothing. The symptoms worsen and all the Drs asked if I've had Covid. I have not but I've had 5 Covid inoculations. I'm 72. I need some answers. I have friends at tge agency. I will pursue this. Please call me. I have my accident card 1st shot in Feb 2021 last one May 2022. 5 in Total
My breasts both became very loose and soft changing in texture; My breasts both became very loose and soft changing in texture and reduced size.; Chest skin changed to white; As well as my nipples and surrounding tissues shrank in size and length; Tissues shrank in size and length; BNT162b2 Dose 2 was administered outside the window period of 19-42 days after Dose 1; This is a spontaneous report from a contactable reporter (consumer or other non HCP). The reporter is the patient.   A 51-year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in left arm, administration date 31Dec2021 at 16:00 (Lot number: unknown) at the age of 51 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19?:Yes; "Long COVID" (unspecified if ongoing); "Pre-diabetic" (unspecified if ongoing) and "Milk allergy" (unspecified if ongoing), notes: Known allergies: Dairy. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: UNKNOWN, Anatomical location: Left arm, Administration time: 14:00), administration date: 01Oct2021, when the patient was 50 years old, for COVID-19 immunisation.  The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 31Dec2021 at 16:00, outcome "unknown", described as "BNT162b2 Dose 2 was administered outside the window period of 19-42 days after Dose 1"; BREAST DISORDER (non-serious) with onset 03Jan2022, outcome "not recovered", described as "My breasts both became very loose and soft changing in texture"; BREAST ATROPHY (non-serious) with onset 03Jan2022, outcome "not recovered", described as "My breasts both became very loose and soft changing in texture and reduced size"; SKIN DISCOLOURATION (non-serious) with onset 03Jan2022, outcome "not recovered", described as "Chest skin changed to white"; NIPPLE DISORDER (non-serious) with onset 03Jan2022, outcome "not recovered", described as "As well as my nipples and surrounding tissues shrank in size and length"; SOFT TISSUE ATROPHY (non-serious) with onset 03Jan2022, outcome "not recovered", described as "Tissues shrank in size and length". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of breast disorder, breast atrophy, skin discoloration, nipple disorder and soft tissue atrophy.  Additional Information: The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Mother states right arm is swollen and red with blisters. Arm looks reddish and blue, mother thinks pt had low grade fever, but did not check.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 12-JAN-2017, the patient was vaccinated with a first dose in vaccination series of GARDASIL intramuscularly (exact dose, lot# and expiry date were not reported) for prophylaxis. On 15-MAR-2017, the patient was vaccinated with a second dose in vaccination series of GARDASIL 9 intramuscularly (exact dose, lot# and expiry date were not reported) for prophylaxis, on 16-JUN-2017 with a third dose of the same vaccine, and on 09-JAN-2018 with the fourth dose (lot# N022952, expiry date 14-JUN-2020) via intramuscular route (exact dose was not reported) for prophylaxis. No adverse effects were reported.
Injection site reaction. 10 cm of erythema & edema tender to palpation. Advised to use OTC BENADRYL & cool compresses.
Left Ear ache; left lymphadenopathy; head ache; muscle & joint aches; muscle & joint aches; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 04Dec2021 15:30 (Lot number: FJ8762) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hashimoto autoimmune thyroid disease" (unspecified if ongoing), notes: Hashimoto autoimmune thyroid disease; "known allergies: Sulfa drugs" (unspecified if ongoing), notes: Hives with sulfa drugs. Concomitant medication(s) included: ESCITALOPRAM; LEVOTHYROXINE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 06Apr2021, when the patient was 50 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EP6955, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 16Mar2021, when the patient was 50 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 04Dec2021 15:30, outcome "unknown", described as "booster"; EAR PAIN (non-serious) with onset 05Dec2021 06:00, outcome "recovered" (Dec2021), described as "Left Ear ache"; LYMPHADENOPATHY (non-serious) with onset 05Dec2021 06:00, outcome "recovered" (Dec2021), described as "left lymphadenopathy"; HEADACHE (non-serious) with onset 05Dec2021 06:00, outcome "recovered" (Dec2021), described as "head ache"; ARTHRALGIA (non-serious), MYALGIA (non-serious) all with onset 05Dec2021 06:00, outcome "recovered" (Dec2021) and all described as "muscle & joint aches". Therapeutic measures were not taken as a result of ear pain, lymphadenopathy, headache, arthralgia, myalgia.  Additional information: patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19.  Since the vaccination, patient has not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.  Follow-Up (13Dec2021): Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL lot # K006960, expiry date 19-FEB-2017, 0.5 ml (route and site of administration were not reported). No adverse effect was reported. Additional information has been requested.
Patient presented to ED for HA, tingling/numbness of fingers and loss of consciousness during shower post Moderna COVID-19 vaccine, dose #2. Vax admin previous day w/only soreness reported by patient after. ED work-up show no concern, skull injury or other concern. Given OTCs for symptom management and discharged home stable.
Breakthrough case admission after 2 vaccines Pfizer 4/7/21 Lot# EW0158;  Pfizer 4/28/21 Lot# Ew72
RASH ON BIL UPPER EXTREMITIES, SOB, CHEST TIGHTNESS, NUMBNESS ONLIPS, 10 MG ZYRTEC GIVEN PO, BENADRYL CREAM APPLIED TOPICALLY TO RASH ON UPPER EXTREMITIES AT 1:10 PM. EXTENDED MONITORING FOR 1 HR WITHI SYMPTOMS LESSENING. VITALS STABLEAT 137/87 BP, HR  76, RR 18, 97% OXYGEN ON ROOM AIR AT 1:50 PM. PATIENT ADVISED TO SEEK ADDITIONAL MEDICAL EVALUATION.
pt developed extreme lightheadedness while driving home 2 hours after vaccine, felt like she was going to pass out.  had to pull over and call EMS.   symptoms lasted for 2 hours before resolving.